Circulating Neuregulin-1 and Galectin-3 can be Prognostic Markers in Breast Cancer
Author:
Affiliation:
1. Experimental Medicine Department, Sapienza University, Rome - Italy
2. Clinical and Molecular Medicine Department, Sapienza University, Rome - Italy
3. Gynecology and Obstetrics Department, Sapienza University, Rome - Italy
Abstract
Publisher
SAGE Publications
Subject
Cancer Research,Clinical Biochemistry,Oncology,Pathology and Forensic Medicine
Link
http://journals.sagepub.com/doi/pdf/10.5301/ijbm.5000262
Reference16 articles.
1. Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells
2. Heregulin in Breast Cancer: Old Story, New Paradigm
3. Neuregulin-1/erbB activities with focus on the susceptibility of the heart to anthracyclines
4. Galectin-3 Protects Human Breast Carcinoma Cells against Nitric Oxide-Induced Apoptosis
5. Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. NRG1 promotes tumorigenesis and metastasis and afatinib treatment efficiency is enhanced by NRG1 inhibition in esophageal squamous cell carcinoma;Biochemical Pharmacology;2023-12
2. NRG1 promotes tumorigenesis and metastasis and afatinib treatment efficiency is enhanced by NRG1 inhibition in esophageal squamous cell carcinoma;2023-07-25
3. Serum levels of VEGF-A, sVEGFR-2 and galectin-3 do not correlate with clinical stage, tumor size, or effectiveness of perioperative chemotherapy in patients with non-metastatic breast cancer;Annales Academiae Medicae Silesiensis;2022-09-29
4. Galectin-3 as a biomarker in breast neoplasms: Mechanisms and applications in patient care;Journal of Leukocyte Biology;2022-09-20
5. Cardioprotective effect of NRG-4 gene expression on spontaneous hypertension rats and its mechanism through mediating the activation of ErbB signaling pathway;Cellular and Molecular Biology;2022-05-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3